undamentalytics Newsletter

ResMed| balance sheet

At the end of fiscal 2026, ResMed| had total assets of $8.97bn, total liabilities of $2.38bn and shareholders' equity of $6.59bn. It held $1.47bn in cash against $659m of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

ResMed|: balance sheet, annual
Fiscal year2010Jun 20102011Jun 20112012Jun 20122013Jun 20132014Jun 20142015Jun 20152016Jun 20162017Jun 20172018Jun 20182019Jun 20192020Jun 20202021Jun 20212022Jun 20222023Jun 20232024Jun 20242025Jun 20252026Jun 2026LTMSept 2026
Cash and equivalents4897358108769067177318221891474632952742282381,2091,4691,011
Receivables2272742833183603633824514845284756145767058379391,036972
Inventory1862011741461652472242682693504174577449988229289461,021
Total current assets9851,2921,3611,4491,5561,4081,4201,6441,0661,1451,5231,5751,9312,3682,3583,5064,3253,509
Goodwill1992352562752892641,0591,0651,0691,8561,8901,9281,9362,7702,8423,0472,9102,908
Total assets1,6262,0692,1382,2112,3612,1823,2573,4683,0644,1084,5874,7285,0966,7526,8728,1748,9668,212
Accounts payable585555618581939393116136138159151238278309321
Deferred revenue (current)3045424542365052618999110109138153166163172
Total current liabilities3132092535742702666383605115566039126897599111,0191,3951,324
Short-term debt122003000—299—1112121210101010260160
Long-term debt010025113013018731,0792701,2591,1646437651,431697658399250
Total debt1221002513013013011,1731,0802811,2711,1766557751,441707668659410
Total liabilities3393385306006035941,5621,5081,0052,0352,0901,8421,7352,6222,0082,2072,3812,264
Shareholders' equity1,2881,7311,6081,6111,7581,5871,6951,9602,0592,0722,4972,8863,3614,1304,8645,9686,5855,948
Shares outstanding151m152m142m142m140m140m141m142m143m144m145m—146m147m147m146m144m141m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: RMD vs STEBLCO vs RMDDXCM vs RMDEW vs RMD

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from ResMed|'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to ResMed|.